Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


Carcinoid Cancer Foundation


Address

333 Mamaroneck Avenue #492
White Plains, NY 10605

Phone

9146831001

Fax

9146830183

800 Number

8887223132

Email Address

carcinoid@optonline.net

Description

The Carcinoid Cancer Foundation (CCF) is a non-profit organization dedicated to encouraging and supporting research and education concerning carcinoid tumors and carcinoid syndrome. A carcinoid tumor is a rare, slow-growing form of cancer characterized by overgrowth of certain cells that secrete serotonin, a naturally occurring derivative of the amino acid tryptophan. Serotonin has many functions including regulating activity of the intestinal tract. In some cases, individuals with carcinoid tumors may experience abnormally increased secretion of serotonin, resulting in carcinoid syndrome. In individuals with carcinoid syndrome, associated symptoms may include intense flushing of the face and upper body, wheezing, weight loss, severe diarrhea, and, in some cases, ulcer-like symptoms and/or eventual heart failure. The Carcinoid Cancer Foundation was established in 1968 to support research that will improve the understanding, diagnosis, and treatment of carcinoid tumor and carcinoid syndrome. It also provides understandable information to affected individuals and family members, engages in professional education, and offers networking services to affected families.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.